Methylprednisolone Completed Phase 4 Trials for Relapsing Remitting Multiple Sclerosis (RRMS)

IndicationsStatusPurposePhase
CompletedNot Available4
clinicaltrials.gov IdentifierTitleDrugs
NCT00112034AVONEX® Combination Trial - ACT